These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37678141)

  • 1. Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation.
    Abd El-Karim SS; Anwar MM; Ahmed NS; Syam YM; Elseginy SA; Aly HF; Younis EA; Khalil WKB; Ahmed KA; Mohammed FF; Rizk M
    Eur J Med Chem; 2023 Nov; 260():115766. PubMed ID: 37678141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
    Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
    Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Ezzat MAF; Abdelhamid SM; Fouad MA; Abdel-Aziz HA; Allam HA
    Drug Dev Res; 2023 Sep; 84(6):1231-1246. PubMed ID: 37243322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
    Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
    Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
    J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
    Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
    J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
    Valasani KR; Chaney MO; Day VW; Shidu Yan S
    J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
    Rodríguez-Lavado J; Gallardo-Garrido C; Mallea M; Bustos V; Osorio R; Hödar-Salazar M; Chung H; Araya-Maturana R; Lorca M; Pessoa-Mahana CD; Mella-Raipán J; Saitz C; Jaque P; Reyes-Parada M; Iturriaga-Vásquez P; Pessoa-Mahana H
    Eur J Med Chem; 2020 Jul; 198():112368. PubMed ID: 32388114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.
    Mehrabi F; Pourshojaei Y; Moradi A; Sharifzadeh M; Khosravani L; Sabourian R; Rahmani-Nezhad S; Mohammadi-Khanaposhtani M; Mahdavi M; Asadipour A; Rahimi HR; Moghimi S; Foroumadi A
    Future Med Chem; 2017 May; 9(7):659-671. PubMed ID: 28485614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation, scaffold hopping of novel donepezil-based compounds as anti-Alzhiemer's agents: synthesis, in-silico and pharmacological evaluations.
    Gupta M; Pant S; Rana P; Kumar A; Prasun C; Nair MS; Paliwal S; Nain S
    Sci Rep; 2024 Jan; 14(1):1687. PubMed ID: 38242995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
    Peauger L; Azzouz R; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Bohn P; Papamicaël C; Levacher V
    J Med Chem; 2017 Jul; 60(13):5909-5926. PubMed ID: 28613859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
    Deb PK; Sharma A; Piplani P; Akkinepally RR
    Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.